Jakarta - PT Bundamedik Tbk (BMHS) bought about 25 million shares or the equivalent of 2% of shares of PT Diagnos Laboratory Utama Tbk (DGNS) from PT Bunda Investama Indonesia (BII).

"The value of the share takeover transaction is Rp8.88 billion," said BMHS Corporate Secretary Josephine Tobing in the IDX's information disclosure in Jakarta Tuesday (6/28).

As of December 31, 2021, BMHS has a 39.20% stake in DGNS, BII is the holding company of BMHS with 57.37% ownership, and BII has a 40.80% stake in DGSN.

BII is a company that operates in financial services such as public relations, self-owned or leased real estate, and other management consulting activities.

In line with the company's business strategy to continuously improve its financial performance, BMHS views health support facilities as one that has an essential role in strengthening the company's health service and hospital ecosystem.

BMHS management belie